Advances in Cancer Research

Edited by

  • George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
  • George Klein, Karolinska Insitutet, Stockholm, Sweden

Audience

Researchers and students in the basic and clinical science of cancer biology and oncology, genetics, immunology, pharmacology, cell and molecular biology.

 

Book information

  • Published: September 2002
  • Imprint: ACADEMIC PRESS
  • ISBN: 978-0-12-006685-8

Reviews

"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences."
PRAISE FOR THE SERIES, —AMERICAN SCIENTIST


"Excellent, highly informative, in-depth reviews...expertly written, up-to-date, and well-referenced."
—JOURNAL OF MEDICINAL CHEMISTRY
"This is a series that has a long tradition of excellence in the field of cancer biology."
—DOODY'S PUBLISHING REVIEWS



Table of Contents

The Von Hippel-Lindau Tumor Suppressor Complex and Regulation of Hypoxia-Inducible Transcription. Retinoblastoma Tumor Suppressor and Genome Stability.The Abl Family Kinases: Mechanisms of Regulation and Signaling.Cellular Immunity to the Her-2/neu Proto-oncogene.A New Challenge for Successful Immunotherapy by Tumors That Are Resistant to Apoptosis: Two Complementary Signals to Overcome Cross-Resistance. Cell Volume and Ion Changes During Apoptotic Cell Death.Mitochondria and Apoptosis: New Therapeutic Targets.